Jim Growcott

561 total citations
12 papers, 462 citations indexed

About

Jim Growcott is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jim Growcott has authored 12 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jim Growcott's work include Prostate Cancer Treatment and Research (4 papers), Cancer-related Molecular Pathways (3 papers) and Advanced Breast Cancer Therapies (2 papers). Jim Growcott is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Cancer-related Molecular Pathways (3 papers) and Advanced Breast Cancer Therapies (2 papers). Jim Growcott collaborates with scholars based in United Kingdom, United States and Australia. Jim Growcott's co-authors include Andrew Hughes, Clifford J. Woolf, Sanchoy Sarkar, Anthony Hobson, Qasim Aziz, David G. Thompson, Robert W. Wilkinson, Ignatius Thomas, Caroline Dive and Kate F. Byth and has published in prestigious journals such as Gastroenterology, Cancer Research and Pain.

In The Last Decade

Jim Growcott

11 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jim Growcott United Kingdom	9	143	129	122	107	85	12	462
Zhuoyuan Lin China	19	101 0.7×	534 4.1×	57 0.5×	161 1.5×	98 1.2×	44	916
B Göke Germany	13	57 0.4×	167 1.3×	97 0.8×	32 0.3×	242 2.8×	35	583
Akira Kurosawa Japan	13	34 0.2×	152 1.2×	50 0.4×	83 0.8×	60 0.7×	39	426
Teresa Ramírez Mexico	11	54 0.4×	186 1.4×	160 1.3×	94 0.9×	43 0.5×	16	465
Wen-Ke Cai China	14	69 0.5×	198 1.5×	73 0.6×	70 0.7×	79 0.9×	32	512
Philippe Golstein Belgium	11	69 0.5×	146 1.1×	36 0.3×	96 0.9×	121 1.4×	23	489
L. J. Miller United States	12	161 1.1×	180 1.4×	46 0.4×	45 0.4×	286 3.4×	25	627
Yoshitaka Toyomasu Japan	17	106 0.7×	162 1.3×	98 0.8×	336 3.1×	238 2.8×	50	736
In Young Choi South Korea	12	85 0.6×	247 1.9×	356 2.9×	47 0.4×	50 0.6×	29	822

Countries citing papers authored by Jim Growcott

Since Specialization

Citations

This map shows the geographic impact of Jim Growcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Growcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Growcott more than expected).

Fields of papers citing papers by Jim Growcott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Growcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Growcott. The network helps show where Jim Growcott may publish in the future.

Co-authorship network of co-authors of Jim Growcott

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Growcott. A scholar is included among the top collaborators of Jim Growcott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Growcott. Jim Growcott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Moore, David, Clare Hodgson, Michael D. Brown, et al.. (2014). Quantification of skeletal metastases in castrate‐resistant prostate cancer predicts progression‐free and overall survival. British Journal of Urology. 114(6b). E70–E73. 22 indexed citations

Moore, David, Alastair Greystoke, Jens Würthner, et al.. (2012). A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients. Clinical Drug Investigation. 32(3). 179–187. 28 indexed citations

Loddick, Sarah A., Luke Gaughan, Jim Growcott, et al.. (2012). Abstract 3848: Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer. Cancer Research. 72(8_Supplement). 3848–3848. 4 indexed citations

Loddick, Sarah A., Sandra R. Brave, Luke Gaughan, et al.. (2011). Abstract B107: Characterization of a small molecule selective androgen receptor downregulator: A novel approach for the treatment of castration-resistant prostate cancer.. Molecular Cancer Therapeutics. 10(11_Supplement). B107–B107.

Byth, Kate F., Andrew P. Thomas, Gareth Hughes, et al.. (2009). AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Molecular Cancer Therapeutics. 8(7). 1856–1866. 104 indexed citations

Cummings, Jeffrey L., Cassandra L. Hodgkinson, Rajesh Odedra, et al.. (2008). Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity. Molecular Cancer Therapeutics. 7(3). 455–463. 50 indexed citations

Pflug, Beth R., et al.. (2007). Defining the basis of an operational model for enhanced efficacy of combination therapy using an endothelin receptor antagonist and chemotherapeutic agents. Molecular Cancer Therapeutics. 6. 5 indexed citations

Camidge, D. Ross, M. N. Pemberton, Jim Growcott, et al.. (2006). A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers. Cancer Chemotherapy and Pharmacology. 60(4). 479–488. 21 indexed citations

Camidge, D. Ross, Dominic Smethurst, Jim Growcott, et al.. (2006). A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers. Cancer Chemotherapy and Pharmacology. 60(3). 391–398. 23 indexed citations

10.

Strauss, Boyd J., et al.. (2003). Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetologica. 40(S1). s266–s269. 43 indexed citations

11.

Sarkar, Sanchoy, Anthony Hobson, Andrew Hughes, et al.. (2003). The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology. 124(1). 18–25. 113 indexed citations

12.

Hughes, Andrew, et al.. (2002). Assessment of the reproducibility of intradermal administration of capsaicin as a model for inducing human pain. Pain. 99(1). 323–331. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact